Caplight Directory>Companies>Boston Medical Sciences, Inc.-preview>Bms-inc


Boston Medical Sciences, Inc.

Boston Medical Sciences, Inc.

Private
TokyoHealthcare & Life Scienceshttps://bms.tech/

Last Round

Series A

Feb 12, 2025

Total Funding Raised

$8.74M

Company Overview

Boston Medical Sciences, Inc. is a healthtech company developing a non-invasive, AI-powered virtual colonoscopy system for colorectal cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts, Hardware + Subscription

AI Layer

Application

Keywords

laxative-free virtual colonoscopyvirtual colonoscopyCT colonographycolorectal cancer screeningvirtual bowel cleansingdigital bowel preppolyp detection AIAI diagnosticsmedical imaging AInon-invasive screeningcancer detectionmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Boston Medical Sciences, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Boston Medical Sciences, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 12, 2025
SeedOct 5, 2023
View all Funding Rounds

Boston Medical Sciences, Inc. Investors

Notable investors and investment history

InvestorRounds
Meiji Yasuda Life Insurance CompanySeries A, Seed
JIC Venture Growth InvestmentsSeries A
Beyond Next VenturesSeries A, Seed
Mitsubishi UFJ CapitalSeries A
Community Healthcare Coordination PlatformSeries A
View all Investors

Boston Medical Sciences, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Boston Medical Sciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Boston Medical Sciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Year Founded2023
Last FundingFeb 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.